Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers

OBJECTIVE: To estimate the prevalence of elevated brain amyloid and reduced cortical thickness (as a marker for neurodegeneration) in a defined population. METHODS: Mayo Clinic Study of Aging participants underwent MRI to assess a composite Alzheimer disease (AD) signature cortical thickness measure...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Roberts, Rosebud O., Knopman, David S., Syrjanen, Jeremy A., Aakre, Jeremiah A., Vassilaki, Maria, Kremers, Walter K., Mielke, Michelle M., Machulda, Mary M., Graff-Radford, Jonathan, Geda, Yonas E., Vemuri, Prashanthi, Lowe, Val, Jack, Clifford R., Petersen, Ronald C.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5711507/
https://ncbi.nlm.nih.gov/pubmed/29030451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000004652
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados